Bronchiolo-Alveolar Adenocarcinoma, also known as bronchioloalveolar carcinoma, is related to nonmucinous bronchioloalveolar adenocarcinoma and mucinous bronchioloalveolar adenocarcinoma, and has symptoms including coughing, dyspnea and fever. An important gene associated with Bronchiolo-Alveolar Adenocarcinoma is NKX2-1 (NK2 Homeobox 1), and among its related pathways/superpathways are IL-1 Family Signaling Pathways and CLEC7A (Dectin-1) signaling. The drugs Gefitinib and Cetuximab have been mentioned in the context of this disorder. Affiliated tissues include lung and endothelial, and related phenotypes are Reduced mammosphere formation and neoplasm